[1]
V. Poltorak, N. Kravchun, M. Gorshunskaya, and N. Krasova, “Glimepiride (Amaryl®) in the Treatment of Patients with Diabetes Mellitus Type 2 (Pathophysiological Rationale and Clinical Implementation)”, Mìžnarodnij endokrinologìčnij žurnal, no. 1.57, pp. 77–89, Mar. 2014.